S&P 500   3,782.78 (-0.34%)
DOW   30,790.36 (-0.65%)
QQQ   314.03 (-0.10%)
AAPL MSFT FB GOOGL AMZN TSLA NVDA BABA CGC GE
S&P 500   3,782.78 (-0.34%)
DOW   30,790.36 (-0.65%)
QQQ   314.03 (-0.10%)
AAPL MSFT FB GOOGL AMZN TSLA NVDA BABA CGC GE
S&P 500   3,782.78 (-0.34%)
DOW   30,790.36 (-0.65%)
QQQ   314.03 (-0.10%)
AAPL MSFT FB GOOGL AMZN TSLA NVDA BABA CGC GE
S&P 500   3,782.78 (-0.34%)
DOW   30,790.36 (-0.65%)
QQQ   314.03 (-0.10%)
AAPL MSFT FB GOOGL AMZN TSLA NVDA BABA CGC GE
Log in
OTCMKTS:ROSGQ

Rosetta Genomics Short Interest Ratio and Short Volume

$0.08
0.00 (0.00 %)
(As of 01/14/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.07
Now: $0.08
$0.09
50-Day Range
$0.01
MA: $0.02
$0.09
52-Week Range
$0.00
Now: $0.08
$0.12
Volume35,443 shs
Average Volume160,938 shs
Market Capitalization$146,400.00
P/E RatioN/A
Dividend YieldN/A
Beta5.92

Short Interest

Rosetta Genomics (OTCMKTS:ROSGQ) Short Interest Data

Current Short Volume:10,500 shares
Previous Short Volume:100 shares
Change Vs. Previous Month:+10,400.00%
Dollar Volume Sold Short:$0.00
Short Interest Ratio / Days to Cover:0.0
Last Record Date:December, 31 2020
Outstanding Shares:1,830,000 shares
Short Percent of Float:0.00%
Today's Trading Volume:35,443 shares
Average Trading Volume:160,938 shares
Today's Volume Vs. Average:-77.98%



Rosetta Genomics (OTCMKTS:ROSGQ) Short Interest History

DateShares Sold ShortDollar Volume Sold ShortPercentage ChangePercentage FloatDays to CoverPrice on Record Date
12/31/202010,500 $0.00 10,400.0%0.0%0.3$0.00
12/15/202010,500 $0.00 10,400.0%0.0%0.3$0.00
11/30/2020100 $1.00 0.0%0.0%0$0.01
11/15/2020100 $0.00 0.0%0.0%0$0.00
10/30/2020100 $1.00 0.0%0.0%0$0.01
10/15/2020100 $0.00 -97.2%0.0%0$0.00

Rosetta Genomics (OTCMKTS:ROSGQ) Short Interest FAQ

speech bubbles
speech bubbles











What is Rosetta Genomics' current short interest?

Short interest is the volume of Rosetta Genomics shares that have been sold short but have not yet been closed out or covered. As of December 31st, traders have sold 10,500 shares of ROSGQ short. 0.00% of Rosetta Genomics' shares are currently sold short. View details.

Is Rosetta Genomics' short interest increasing or decreasing?

Rosetta Genomics saw a increase in short interest during the month of December. As of December 31st, there was short interest totaling 10,500 shares, an increase of 10,400.0% from the previous total of 100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Rosetta Genomics' short interest compare to its competitors?

0.00% of Rosetta Genomics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Rosetta Genomics: Adhera Therapeutics, Inc. (0.00%), Anthera Pharmaceuticals, Inc. (0.00%), Achaogen, Inc. (0.00%), Targeted Medical Pharma, Inc. (0.00%), EPIRUS Biopharmaceuticals, Inc. (0.00%), Sienna Biopharmaceuticals, Inc. (0.00%), PhaseRx, Inc. (0.00%), Abliva AB (publ) (0.00%), Affymax, Inc. (0.00%), and ARYx Therapeutics, Inc. (0.00%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($5.18 billion), ViacomCBS Inc. ($4.71 billion), Analog Devices, Inc. ($4.45 billion), Aon Plc ($4.28 billion), Snap Inc. ($3.70 billion), Moderna, Inc. ($3.00 billion), The Clorox Company ($2.46 billion), Peloton Interactive, Inc. ($2.40 billion), The Kroger Co. ($2.38 billion), and Expedia Group, Inc. ($2.37 billion). View all of the most shorted stocks.

What does it mean to sell short Rosetta Genomics stock?

Short selling ROSGQ is an investing strategy that aims to generate trading profit from Rosetta Genomics as its price is falling. To short Rosetta Genomics stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Rosetta Genomics will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Rosetta Genomics?

A short squeeze for Rosetta Genomics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ROSGQ, which in turn drives the price of the stock up even further.

How often is Rosetta Genomics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ROSGQ, twice per month. The most recent reporting period available is December, 31 2020.


This page was last updated on 1/15/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.